A decision, likely to come in June, would be a major victory for the FDA’s authority to regulate prescription drugs and for abortion-rights advocates who have sought to protect access to mifepristone.
Related Posts
Why an expanded Obamacare is even harder to repeal today
- admin
- December 2, 2023
- 0
Now, he said in an interview Thursday, while he remains critical of the law, “it’s not that simple.” Idaho, Maine, Missouri, Nebraska, North Carolina, Oklahoma, […]
The MAGA backlash to Trump’s MAHA surgeon general pick
- admin
- May 9, 2025
- 0
Casey Means and brother Calley are favorites of HHS Secretary Robert F. Kennedy Jr.
What can Trump do about vaccines? More than you might think.
- admin
- June 10, 2024
- 0
His new anti-vaccine persona could have far-reaching consequences if he’s elected to a second stint as president with far-reaching administrative powers.
